Prospective cohort study of medication for inflammatory bowel disease

Prospective cohort study of medication for inflammatory bowel disease - Prospective cohort study of medication for inflammatory bowel disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028089

Enrollment

600

Registered

2017-07-06

Start date

2017-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Ministry of Health, Labor and Welfare Survey Study on Intractable Inflammatory Bowel Disease Disorder Patients newly intervening therapeutically among cases diagnosed as ulcerative colitis or Crohn's disease according to diagnostic criteria. 2 Patient who obtained consent of this study. 3 Patients over 16 years of age.

Exclusion criteria

Exclusion criteria: 1 patients suspected of having intestinal inflammation other than UC and Crohn's disease (infectious enteritis, etc.). 2 Patients with symptomatic digestive tract stenosis. 3 Patient planning resection of colon. 4 Severe infections Patients with complications. 5 Other patients who judged that the physician in charge is inappropriate to incorporate into this study.

Design outcomes

Primary

Measure	Time frame
The rate of clinical efficacy at 8 weeks after initiation of treatment	—

Countries

Japan

Contacts

Public ContactMakoto Naganuma

School of Medicine, Keio University Gastroenterology and Hepatology

nagamakoto@keio.jp03-3353-1211

Outcome results